BMSs Opdivo Misses Again In Glioblastoma Phase III Trial
BMS’s Opdivo Misses Again In Glioblastoma Phase III Trial
07:05 EDT 10 May 2019 |
SCRIP
A second failure for BMS’s Opdivo in brain cancer leaves it with just one final chance in newly diagnosed disease...
Original Article: BMS’s Opdivo Misses Again In Glioblastoma Phase III Trial
More From BioPortfolio on "BMS’s Opdivo Misses Again In Glioblastoma Phase III Trial"